-
Sanofi: Cutting Three Pipeline Programs
Sanofi
In Q3 2024, Sanofi reported a 15.7% increase in sales to €13.4 billion, driven by vaccine sales. The company removed three studies from its pipeline while achieving key regulatory approvals and positive trial results for several products, including Dupixent.
-
-
-
-
-
-
-
-
-
寻乌县|
嘉义市|
遂溪县|
巢湖市|
桃园市|
乐陵市|
英吉沙县|
滨州市|
博湖县|
嫩江县|
从江县|
静乐县|
商洛市|
西丰县|
海丰县|
英吉沙县|
郎溪县|
宁远县|
临夏市|
抚远县|
江门市|
吉隆县|
平泉县|
荆州市|
合江县|
武威市|
澎湖县|
壶关县|
北宁市|
潍坊市|
伊川县|
什邡市|
资阳市|
防城港市|
弥渡县|
迭部县|
托里县|
黄大仙区|
凤阳县|
洪泽县|
嘉荫县|